Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Fumiko Matsuoka

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
Cancer Immunology, Immunotherapy : CII|October 11, 2003
Antitumor effects of combined therapy of recombinant heat shock protein 70 and hyperthermia using magnetic nanoparticles in an experimental subcutaneous murine melanomaAkira Ito, Fumiko Matsuoka, Hiroyuki Honda, et al.
Cancer Gene Therapy|January 9, 2004
Heat shock protein 70 gene therapy combined with hyperthermia using magnetic nanoparticlesAkira Ito, Fumiko Matsuoka, Hiroyuki Honda, et al.
Biomagnetic Research and Technology|March 26, 2004
Hyperthermia using magnetite cationic liposomes for hamster osteosarcomaFumiko Matsuoka, Masashige Shinkai, Hiroyuki Honda, et al.
Biotechnology and Bioengineering|January 15, 2014
Characterization of time-course morphological features for efficient prediction of osteogenic potential in human mesenchymal stem cellsFumiko Matsuoka, Ichiro Takeuchi, Hideki Agata, et al.
Plos One|February 26, 2013
Morphology-based prediction of osteogenic differentiation potential of human mesenchymal stem cellsFumiko Matsuoka, Ichiro Takeuchi, Hideki Agata, et al.
International Journal of Hematology|September 15, 2017
Phase I study of panobinostat and 5-azacitidine in Japanese patients with myelodysplastic syndrome or chronic myelomonocytic leukemiaYukio Kobayashi, Wataru Munakata, Michinori Ogura, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
Cancer Immunology, Immunotherapy : CII|October 11, 2003
Antitumor effects of combined therapy of recombinant heat shock protein 70 and hyperthermia using magnetic nanoparticles in an experimental subcutaneous murine melanomaAkira Ito, Fumiko Matsuoka, Hiroyuki Honda, et al.
Cancer Gene Therapy|January 9, 2004
Heat shock protein 70 gene therapy combined with hyperthermia using magnetic nanoparticlesAkira Ito, Fumiko Matsuoka, Hiroyuki Honda, et al.
Biomagnetic Research and Technology|March 26, 2004
Hyperthermia using magnetite cationic liposomes for hamster osteosarcomaFumiko Matsuoka, Masashige Shinkai, Hiroyuki Honda, et al.
Biotechnology and Bioengineering|January 15, 2014
Characterization of time-course morphological features for efficient prediction of osteogenic potential in human mesenchymal stem cellsFumiko Matsuoka, Ichiro Takeuchi, Hideki Agata, et al.
Plos One|February 26, 2013
Morphology-based prediction of osteogenic differentiation potential of human mesenchymal stem cellsFumiko Matsuoka, Ichiro Takeuchi, Hideki Agata, et al.
International Journal of Hematology|September 15, 2017
Phase I study of panobinostat and 5-azacitidine in Japanese patients with myelodysplastic syndrome or chronic myelomonocytic leukemiaYukio Kobayashi, Wataru Munakata, Michinori Ogura, et al.
Pageof 1